Mankind Pharma Clears Broadway Hospitality Sale, Plans Netherlands R&D Vehicle

MT Newswires Live
07/13

Mankind Pharma (BOM:543904, NSE:MANKIND) approved the sale of its wholly owned subsidiary, Broadway Hospitality Services, according to an exchange filing Saturday.

The company will sell its entire stake in Broadway to AKRK Projects and Partners for 4.90 billion rupees, subject to closing adjustments.

The transaction is expected to be completed within 90 days as part of Mankind Pharma's strategy to divest non-core assets.

Separately, Mankind Pharma approved the incorporation of a wholly owned subsidiary in the Netherlands as a special purpose vehicle to hold R&D investments and support business development in niche therapies.

The company plans to invest up to 5 million euros in the Dutch unit in one or more tranches to fund its setup, operations, procurement, and future investments.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10